Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bryan Bell

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Microsurgery|October 10, 2015
Survival of microvascular free flaps in mandibular reconstruction: A systematic review and meta-analysisMichael R Markiewicz, R Bryan Bell, Tuan G Bui, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|November 7, 2017
Functional Anatomic Computer Engineered Surgery Protocol for the Management of Self-Inflicted Gunshot Wounds to the Maxillofacial SkeletonBaber Khatib, Karl Cuddy, Allen Cheng, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|June 15, 2012
Accuracy of a computer-aided surgical simulation protocol for orthognathic surgery: a prospective multicenter studySam Sheng-Pin Hsu, Jaime Gateno, R Bryan Bell, et al.
Journal for Immunotherapy of Cancer|July 5, 2019
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distanceMarcus A Couey, R Bryan Bell, Ashish A Patel, et al.
Oral Oncology|February 17, 2017
Erratum to 'Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy' [Oral Oncol. 61 (2016) 166-176]R Bryan Bell, Michael J Gough, Steven K Seung, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2021
Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!Michele Maio, Christian Blank, Andrea Necchi, et al.
Clinical & Translational Immunology|May 20, 2016
OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancerRyan Montler, R Bryan Bell, Colin Thalhofer, et al.
Nature Communications|May 14, 2021
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasisHongjun Li, Zejun Wang, Zhaowei Chen, et al.
Oral Oncology|November 29, 2015
OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironmentR Bryan Bell, Rom S Leidner, Marka R Crittenden, et al.
Oncotarget|July 1, 2021
A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resectionShay Sharon, Jason R Baird, Shelly Bambina, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Microsurgery|October 10, 2015
Survival of microvascular free flaps in mandibular reconstruction: A systematic review and meta-analysisMichael R Markiewicz, R Bryan Bell, Tuan G Bui, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|November 7, 2017
Functional Anatomic Computer Engineered Surgery Protocol for the Management of Self-Inflicted Gunshot Wounds to the Maxillofacial SkeletonBaber Khatib, Karl Cuddy, Allen Cheng, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|June 15, 2012
Accuracy of a computer-aided surgical simulation protocol for orthognathic surgery: a prospective multicenter studySam Sheng-Pin Hsu, Jaime Gateno, R Bryan Bell, et al.
Journal for Immunotherapy of Cancer|July 5, 2019
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distanceMarcus A Couey, R Bryan Bell, Ashish A Patel, et al.
Oral Oncology|February 17, 2017
Erratum to 'Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy' [Oral Oncol. 61 (2016) 166-176]R Bryan Bell, Michael J Gough, Steven K Seung, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2021
Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!Michele Maio, Christian Blank, Andrea Necchi, et al.
Clinical & Translational Immunology|May 20, 2016
OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancerRyan Montler, R Bryan Bell, Colin Thalhofer, et al.
Nature Communications|May 14, 2021
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasisHongjun Li, Zejun Wang, Zhaowei Chen, et al.
Oral Oncology|November 29, 2015
OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironmentR Bryan Bell, Rom S Leidner, Marka R Crittenden, et al.
Oncotarget|July 1, 2021
A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resectionShay Sharon, Jason R Baird, Shelly Bambina, et al.
Pageof 13